Navigation Links
Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
Date:11/11/2008

to 18.6 percent of those in the placebo group at 12 weeks. However, by the 24th week, the placebo group had improved slightly and the difference between groups was not statistically significant.

The quality of life score, as measured by the Minnesota Living with Heart Failure Questionnaire, improved continuously during treatment, and was more pronounced in the enterovirus/adenovirus subgroup than in the subgroup with parvovirus. Those findings also fell short of statistical significance when compared with placebo.

Researchers reported no safety issues. The study tested two different dosages of interferon. Because both dosages appeared equally effective in viral elimination, the researchers combined the results for both interferon groups into one group for comparison with the placebo group.

The 143 patients randomized to interferon or placebo all had chronic heart failure and the presence of one of three viruses -- adenovirus, enterovirus and parvovirus B19 -- as shown by specimens obtained by heart biopsy. A total of 131 patients completed the study, which required a second heart biopsy to determine viral load after treatment.

The researchers divided the participants into one of three treatment arms: the first two groups got one of two doses of interferon and the third received a placebo, an inactive medication indistinguishable from the interventional drug given subcutaneously (under the skin) every other day for 24 weeks.

The primary endpoint was the absence of adenovirus, enterovirus and parvovirus in biopsies taken an average of 12 weeks after treatment ended. For the parvovirus group, virus elimination was assessed with a quantitative assay. Schultheiss said IFNB-1b resulted in clearance of all enteroviruses and adenoviruses, but noted that parvovirus persisted in some of the double infected patients.

According to the definition of the primary endpoint, only patients with complete clearance of both viruses were calcula
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study shows that high-dose, high-frequency interferon produces no additional benefit
2. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Interferon does not slow or stop hepatitis C from worsening, study finds
5. For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution
6. Ultra-High Pressure Processing Eliminates Salmonella in Fresh Tomatoes
7. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
8. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Doctor Recommends New Powerful Natural Antiviral Against the Flu
11. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/2/2014)... Arizona (PRWEB) August 02, 2014 ... the nation's number one provider of customized medical and ... two major dental-industry conferences this fall. CEDR’s CEO will ... in September and early December. , From September 4-6, ... Dental Office Managers (AADOM) Dental Managers Conference in San ...
(Date:8/1/2014)... 02, 2014 Recently, iFitDress.com, one of the ... new assortment of top bridesmaid dresses online. At ... promotional prices, up to 52% off. According to the company’s ... of August. , The company’s stock is limited. Those ... its online store as soon as possible. All its products ...
(Date:8/1/2014)... University School of Medicine in St. Louis helps explain ... frequently are more harmful than similar tumors in females. ... are diagnosed twice as often in males, who suffer ... as long. , The researchers found that retinoblastoma protein ... significantly less active in male brain cells than in ...
(Date:8/1/2014)... New York, New York (PRWEB) August 01, 2014 ... ) filed in the wake of the 2012 ... continue to move forward in New Jersey’s Bergen ... to documents filed in the proceeding, the Court ... Order of Confidentiality governing any and all hard ...
(Date:8/1/2014)... New York (PRWEB) August 01, 2014 ... ) on behalf of women who allegedly experienced the ... power morcellators in gynecological surgeries, Bernstein Liebhard LLP notes ... withdraw a number of power morcellators marketed by its ... report from The New York Times, some critics of ...
Breaking Medicine News(10 mins):Health News:Nuanced Media Client, CEDR HR Solutions, to Speak at Upcoming Major Dental Conferences 2Health News:Nuanced Media Client, CEDR HR Solutions, to Speak at Upcoming Major Dental Conferences 3Health News:iFitDress.com: Top Bridesmaid Dresses For The Global Customers 2Health News:Study reveals one reason brain tumors are more common in men 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 2Health News:Stryker Hip Lawsuit News: New Order Issued in New Jersey Stryker Hip Recall Litigation, Bernstein Liebhard LLP Reports 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4
... of Houston (UH) has invited best-selling author and noted physician ... in Family, Health and Human Values at 7:30 p.m., Monday, ... "As an Indian-American immigrant to the United States, Dr. ... inaugurate the new India studies program at UH," said Lois ...
... A UCSF study gives hope to those suffering from severe ... if left untreated. The use of topical corticosteroids in a ... harmful in the overall patient population in the study. However, ... corneal ulcers, according to UCSF researchers. In a paper ...
... , TUESDAY, Oct. 18 (HealthDay News) -- Colorectal cancers ... the cancer and could prove important in diagnosing, treating and ... the Dana-Farber Cancer Institute and the Broad Institute in Boston ... of colorectal cancer tissue and found unusually high numbers of ...
... HealthDay Reporter , MONDAY, Oct. 17 (HealthDay News) ... Pap tests as a cervical cancer screening tool among ... The U.S. Preventive Services Task Force published ... are now seeking to fine-tune these guidelines. The results ...
... -- Unstructured play is much better than TV or videos ... American Academy of Pediatrics policy statement says. Free play ... solve, and develop reasoning and motor skills at an early ... pediatric experts pointed out in an AAP news release. ...
... has found that coughing may signal trouble for patients with ... published in the journal Respirology , found that patients ... develop advanced forms of the disease that may be life ... the lungs becomes thick and scarred, likely due to a ...
Cached Medicine News:Health News:Dr. Abraham Verghese to give John P. McGovern Lecture on Oct. 24 2Health News:UCSF study finds steroids could help heal some corneal ulcers 2Health News:Link Explored Between Colon Cancer, Bacterium 2Health News:Pap Test Still Best for Cervical Cancer Screening, Experts Say 2Health News:Pap Test Still Best for Cervical Cancer Screening, Experts Say 3Health News:'Screen-Free' Play Best for Toddlers' Brains 2Health News:Cough may warn of danger for patients with lung-scarring disease 2
(Date:8/1/2014)... Aug. 1, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 ... Nitrate Industry" and "2014 Deep Research Report on ... to its research database. Photo ... Deep Research Report on Global and China Potassium ... report on China and ...
(Date:7/31/2014)... STAAR Surgical Company (NASDAQ: STAA ) a ... delivery systems for the eye today reported revenue for ... million, a 10% increase over $18.2 million reported for ... basis, revenues grew 11% during the second quarter of ... effect of foreign currency exchange reduced sales by $0.1 ...
(Date:7/31/2014)... Xencor Inc. (NASDAQ: XNCR ), a ... the treatment of autoimmune diseases, asthma and allergic ... the second quarter ended June 30, 2014 and provided ... "In the second quarter, we presented preclinical data ... (ATS) demonstrating three novel mechanisms of action of ...
Breaking Medicine Technology:Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 2Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 3Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 4Potassium Nitrate Market & Tricalcium Phosphate Industry Analysis for Global & China Regions 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Xencor Reports Second Quarter 2014 Financial Results 2
... 1, 2011    Advanced Biologics, ( www.advancedbiologics.com ) ... newest product within the OsteoAMP ® platform ... meeting this week in Chicago, IL.  OsteoAMP Structural ... that demonstrates osteoinductive properties in-vivo.  Initial product offerings ...
... 2011 Merz Aesthetics, Inc., the exclusive distributor of ... launch of the "STAND AND DELIVER" program.  In partnership ... selected for their significant abilities to STAND AND DELIVER, ... a stand by making a difference in their communities. ...
Cached Medicine Technology:Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society 2Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 2Merz Aesthetics and Inspirational Women Join Forces to Recognize Women Who STAND AND DELIVER 3
... has been designed for use with Bioneer's ... can handle 96 samples (Plasmid DNA, Genomic ... and purification. While conventional kits use centrifugal ... BioVac 96 Vacuum Manifold uses vacuum pressure ...
Plastic Tray Type Vacuum Manifold...
... manifold is designed to efficiently process ... holds one deep well plate and ... are drawn through the wells ... microplates. The base holds and ...
QIAvac 96 is designed for efficient processing of QIAGEN 96-well plates....
Medicine Products: